Google
MTLS 株価分析 — MATERIALISE NV (Technology >> Software - Application)
MTLS に関するよくある質問
MTLSのPER（株価収益率）は？
MATERIALISE NV（MTLS）は現在PER 35.71倍で取引されています。
MTLSのROE（自己資本利益率）は？
MATERIALISE NVのROEは4.07%です。
MTLSの配当利回りは？
MATERIALISE NVの配当利回りは0.00%です。
MTLSの品質スコア（Quality Score）は？
当社のAIはMTLSの総合財務品質を100点中38点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
MTLSは今が買い時ですか？
当社AIのタイミングスコアは100点中56点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
MTLSはどのセクターに属しますか？
MATERIALISE NVはTechnology >> Software - Applicationセクターに分類されます（NASDAQ市場）
MTLS AI Analysis Summary
Our AI summary for MTLS: MATERIALISE NV (NASDAQ), Technology >> Software - Application sector. The stock currently trades at a P/E of 35.71, ROE of 4.07%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 56/100 — technical signals are mixed; watch for a clearer trend. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 6.35
Price
-0.06
(-0.94%)
Day Change
|
|
|---|
MTLS, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そして テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROEの伸びが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROAの伸びが低い
NPMが低い
NPMの伸びが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 63 |
| Magic Formula Rank by ROA |
2728
|
| Magic Formula Rank by ROE |
2728
|
| Magic Formula Rank by ROIC |
2842
|
| Price | 6.35 |
| PBV / Sector |
1.45 / 30.40
GOOD
|
| Earning Per Share | 0.18 |
| PE / Sector |
35.71 / 32.04
|
| PEG or PE/Growth / Sector |
-0.30 / 0.20
|
| Average 1M Daily Value |
0.41 M
GREAT
|
| Average 1W Daily Value |
0.36 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
45% |
| ポイントになる統計 |
|
58% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-01 08:00:12 |
| Symbol | MTLS |
| Name | MATERIALISE NV |
| Sector | Technology >> Software - Application |
| Market | NASDAQ |
| Listed Shares | 57.91 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 371.20 / 16,243.98 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Technologielaan 15, Leuven, Belgium, 3001
Phone: 32 1 639 66 11
Website: https://www.materialise.com
Employees: 2,556
Description: Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
Analyst Ratings & Target Price
ME vs SECTOR Technology >> Software - Application
Click a bubble to view stock details · Bubble size represents market capitalization share
